LENALIDOMIDA ALVOGEN 25mg capsules medication leaflet

L04AX04 lenalidomide • Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants

Lenalidomide is a medication used for the treatment of multiple myeloma, myelodysplastic syndromes, and other hematologic conditions. It works by modulating the immune system and inhibiting tumor cell growth.

The medication is taken orally, usually once daily, as part of a treatment cycle prescribed by a doctor. Regular monitoring of hematologic function is important, and precautions must be taken to avoid pregnancy.

Side effects may include fatigue, anemia, neutropenia, or skin rashes. In rare cases, deep vein thrombosis or severe allergic reactions may occur.

Lenalidomide is not recommended for pregnant women or those planning to become pregnant, as well as patients with hypersensitivity to this medication.

General data about LENALIDOMIDA ALVOGEN 25mg

Substance: lenalidomide

Date of last drug list: 01-06-2025

Commercial code: W64960001

Concentration: 25mg

Pharmaceutical form: capsules

Quantity: 21

Product type: generic

Price: 13817.85 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMADOX HEALTHCARE LTD. - MALTA

Holder: ALVOGEN MALTA OPERATIONS (ROW) LTD. - MALTA

Number: 10941/2018/01

Shelf life: 3 years

Concentrations available for lenalidomide

10mg, 15mg, 2.5mg, 20mg, 25mg, 5mg, 7.5mg

Compensation lists for LENALIDOMIDA ALVOGEN 25mg ALVOGEN

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

13817.85 RON

1585.75 RON

12232.10 RON